SCHEMBL21045993

SCHEMBL21045993

CC(=NOc1ccc(F)cc1)c1c(C)cc(=O)n(O)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAOB P27338 2/20 0.33
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.31
TTR P02766 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
RAB9A P51151 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
ALOX15 P16050 1/20 0.30
ALOX5 P09917 1/20 0.30
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
MAOA P21397 1/20 0.30
PTBP1 P26599 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045992 1.00 MEN1 (0.49) MEN1KMT2AMAOBLMNASMN1; SMN2
SCHEMBL21045983 0.87 MEN1 (0.57) MEN1KMT2ALMNASMN1; SMN2RAB9A
SCHEMBL21045982 0.87 MEN1 (0.57) MEN1KMT2ALMNASMN1; SMN2RAB9A
SCHEMBL21045900 0.82 MEN1 (0.46) MEN1KMT2AMAOBLMNASMN1; SMN2
SCHEMBL21045902 0.82 MEN1 (0.46) MEN1KMT2AMAOBLMNASMN1; SMN2
SCHEMBL21045901 0.82 MEN1 (0.46) MEN1KMT2AMAOBLMNASMN1; SMN2
SCHEMBL21045961 0.74 MEN1 (0.46) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL21045960 0.74 MEN1 (0.46) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL21045962 0.74 MEN1 (0.46) MEN1KMT2ALMNASMN1; SMN2HTT
SCHEMBL24121622 0.71 MEN1 (0.73) MEN1KMT2ALMNAHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same ARBUTUS BIOPHARMA CORPORATION (CA) 2020-02-04 US disclosed
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550084-B2 Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885MAOB 343/4885
US-20190169128-A1 SUBSTITUTED 1-HYDROXY-PYRIDIN-2(1H)-ONES, AND METHODS OF MAKING AND USING SAME RNASEH1, RNASE1, RNASEL MEN1 1891/4885KMT2A 1917/4885MAOB 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.